Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

A retrospective study of children's perceptions of participation as clinical research subjects in a minimal risk study.

Fogas BS, Oesterheld JR, Shader RI.

J Dev Behav Pediatr. 2001 Aug;22(4):211-6.

PMID:
11530893
2.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

3.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
5.

[Methylphenidate in the treatment of attention-deficit/hyperactivity disorder: are we achieving an adequate clinical practice?].

Gonzalez de Dios J, Cardó E, Servera M.

Rev Neurol. 2006 Dec 16-31;43(12):705-14. Review. Spanish.

6.

[Diagnostic structured interviews in child and adolescent's psychiatry].

Renou S, Hergueta T, Flament M, Mouren-Simeoni MC, Lecrubier Y.

Encephale. 2004 Mar-Apr;30(2):122-34. Review. French.

PMID:
15107714
7.

Methylphenidate transdermal system: In attention-deficit hyperactivity disorder in children.

Anderson VR, Scott LJ.

Drugs. 2006;66(8):1117-26. Review.

PMID:
16789796
8.

Balancing recruitment and protection: children as research subjects.

Meaux JB, Bell PL.

Issues Compr Pediatr Nurs. 2001 Oct-Dec;24(4):241-51. Review.

PMID:
11769209
9.

Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/ Hyperactivity Disorder.

Greenhill L, Beyer DH, Finkleson J, Shaffer D, Biederman J, Conners CK, Gillberg C, Huss M, Jensen P, Kennedy JL, Klein R, Rapoport J, Sagvolden T, Spencer T, Swanson JM, Volkow N.

J Atten Disord. 2002;6 Suppl 1:S89-100. Review.

PMID:
12685523
10.

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.

Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML; American Academy of Pediatrics Committee on Quality Improvement; American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder.

Pediatrics. 2005 Jun;115(6):e749-57. Review.

PMID:
15930203
11.

[Methylphenidate of retard forms in children and adolescents with ADHD - an overview].

Pelz R, Banaschewski T, Becker K.

Klin Padiatr. 2008 Mar-Apr;220(2):93-100. Epub 2007 Dec 21. Review. German.

PMID:
18157763
13.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
14.

Issues in pediatric research: safeguarding the children.

Conrad B, Horner S.

J Soc Pediatr Nurs. 1997 Oct-Dec;2(4):163-71. Review.

PMID:
9444643
15.

Altruism and the volunteer: psychological benefits from participating as a research subject.

Seelig BJ, Dobelle WH.

ASAIO J. 2001 Jan-Feb;47(1):3-5. Review.

PMID:
11199310

Supplemental Content

Support Center